verified SJR 0,535 · Q3 • database Scopus / SJR & Web of Science indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q3 — Immunology and Allergy lock Subscription

Endocrine, Metabolic and Immune Disorders - Drug Targets

Endocrine, Metabolic and Immune Disorders - Drug Targets is a journal indexed in SJR in Immunology and Allergy and Endocrinology, Diabetes and Metabolism with an H index of 66. It has an SJR impact factor of 0,535 and it has a best quartile of Q3. It has an SJR impact factor of 0,535.

ISSN: 1871-5303

Publisher: Bentham Science Publishers

Category: Immunology and Allergy

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,535 Q3

H-index 66

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,535

H-index

Docs (year)

173

Docs 3y

562

Total refs

12634

Cites 3y

1191

Citable 3y

533

Cites/Doc 2y

2.03

Ref/Doc

73.03

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cefdinir Microsphere Modulated Microflora and Liver Immunological Response to Diet Induced Diabetes in Mice

Vitamin D levels correlate with Metabolic Syndrome Criteria in Algerian Patients: The Ex-vivo Immuomodulatory Effect of a, 25 Dihydroxyvitamin D3

Editorial [ Sepsis: From the Bench to the Bedside ]

Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example

Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?

Dimeric NGF Mimetic Attenuates Hyperglycaemia and DNA Damage in Mice with Streptozotocin-Induced Early-Stage Diabetes

Differential Conservation of Nucleotides and Conservation/Mutation Correlations Between Nucleotides, with Special Reference to CXC 1 and 4 and FP Receptors Involved in Immune Regulation

Describing the Potential Crossreactome between Mumps Virus and Spermatogenesis-Associated Proteins

Correlations between the Youth Healthy Eating Index, Body Mass Index and the Salivary Nitric Oxide Concentration in Overweight/Obese Children

Comparison of Different Usage of Cyclophosphamide in Lupus Nephritis: A Meta-analysis of Randomized Controlled Trails

Coagulation and Sepsis

Characterization of the Immune Inflammatory Profile in Obese Asthmatic Children

SHOW MORE ARTICLES

Cerebrovascular Complications of Diabetes: Focus on Stroke

A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer

CCL2-CCR2 Signaling in Disease Pathogenesis

Blockade of Chemokine-Mediated Tissue Injury in Lupus Nephritis

Biomarkers of Osteoporosis: An Update

Bacterial Translocation, Microcirculation Injury and Sepsis

Bacterial Recognition and Induced Cell Activation in Sepsis

Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases

Anti-Diabetic Effect of a Flavonoid and Sitosterol - Rich Aqueous Extract of Pleurotus tuberregium Sclerotia in Alloxan-Induced Diabetic Rabbits

Anti-Diabetic and Angio-Protective Effect of Guluronic Acid (G2013) as a New Nonsteroidal Anti-Inflammatory Drug in the Experimental Model of Diabetes

Anemia in Patients with Diabetic Foot Ulcer: Effects on Diabetic Microvascular Complications and Related Conditions

Analysis Of Interleukin-1 Receptor Antagonist Variable Number Tandem Repeat Variant in Recurrent Aphthous Stomatitis

FAQs

Endocrine, Metabolic and Immune Disorders - Drug Targets has an SJR of 0,535 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Endocrine, Metabolic and Immune Disorders - Drug Targets is 29%.

Endocrine, Metabolic and Immune Disorders - Drug Targets

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Endocrine, Metabolic and Immune Disorders - Drug Targets?

What is the APC / publication cost?

What is the acceptance rate?